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tiques de type 2 asymptomatiques ne présentent aucune plaque coronarienne détectable par
scanner multidétecteur malgré la présence concomitante de lésions d’athérosclérose caroti-
diennes. Le scanner semble détecter une proportion importante de plaques coronariennes en
ie co
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Summary
Background.— There is a need to identify diabetic patients at risk of cardiovascular events
before symptom onset.
Aims.— To evaluate the prevalence and characteristics of coronary atherosclerotic plaques in
asymptomatic type 2 diabetic patients with coronary risk factors but without known coronary
artery disease, using multidetector computed tomography.
Methods.— High-resolution 40-slice coronary computed tomography was performed prospec-
tively in 42 consecutive type 2 diabetic patients (mean age 62 years; range 50—77 years; 28men)
with over one or more carotid atherosclerotic plaque and no coronary artery disease symptoms.
Computed tomography data were evaluated for calcium score and the presence of coronary
plaques. Plaque type, distribution, extensive character and obstructive nature were determined
per patient for each segment.
Results.— No plaques were detected in 11 (26.2%) patients. Atherosclerotic plaques were
detected in 31 (73.8%) patients. A total of 147 coronary segments with plaque were identi-
ﬁed, of which 11 (7.5%) contained hypodense plaques, 28 (19%) mixed plaques and 108 (73.5%)
calciﬁed plaques. Hypodense plaques were noted in 4/15 (26.7%) patients without coronary
calciﬁcations. Most calciﬁed and hypodense plaques resulted in lumen narrowing of less than
50%; most mixed plaques resulted in lumen narrowing greater than 50%. Obstructive disease
was detected in 9/11 patients with a high calcium score (> 400).
Conclusion.— This preliminary study demonstrates that a high proportion of asymptomatic type
2 diabetic patients present without coronary plaques detectable by multidetector computed
tomography, despite concomitant carotid atherosclerotic lesions. Computed tomography seems
to detect a high proportion of plaques compared with conventional angiography in these speciﬁc
patients.
© 2009 Elsevier Masson SAS. All rights reserved.
Résumé
Contexte.— Il y a un intérêt à identiﬁer les patients diabétiques à risque d’événements cardio-
vasculaires avant le début des symptômes.
Objectifs.— Évaluer la prévalence et les caractéristiques des plaques d’athérosclérose coro-
nariennes chez des patients asymptomatiques diabétiques de type 2 à risque coronarien mais
sans atteinte coronarienne connue par scanner multibarette.
Méthodes.— Un coroscanner 40 détecteurs a été réalisé de manière prospective chez
42 patients consécutifs diabétiques de type 2 (28 hommes ; âge moyen, 62 ans ; extrêmes,
50—77 ans) ayant au moins une plaque d’athérosclérose carotidienne et asymptomatiques sur
un plan coronarien. Le score calcique et la présence de plaques coronariennes ont été évalués à
partir des données scannographiques. Le type, la distribution le caractère extensif et la nature
obstructive des plaques ont été déterminés par patient pour chaque segment.
Résultats.— Aucune plaque coronarienne n’a été détectée chez 11 (26,2 %) patients. La
présence de plaques d’athérosclérose a été détectée chez 31 (73,8 %) patients. Un total
de 147 segments coronaires avec des plaques ont été identiﬁés, parmi lesquels 11 (7,5 %)
contenaient des plaques hypodenses, 28 (19 %) des plaques mixtes et 108 (73,5 %) des plaques
calciques. La présence de plaques hypodenses était notée chez quatre (26,7 %) des 15 patients
qui n’avaient pas de calciﬁcations coronariennes. La majorité des plaques calciﬁées et hypo-
denses étaient non obstructives alors que la majorité des plaques mixtes étaient obstructives.
La présence d’une maladie obstructive a été notée chez neuf des 11 patients avec un score
calcique élevé (> 400).
Conclusion.— Cette étude préliminaire démontre qu’une proportion élevée de patients diabé-ubjects [1—3], and coronary artery lesions have been
roven angiographically to be more extensive and CAD
as a worse prognosis [4,5]. Moreover, silent myocardial
schaemia occurs more frequently in diabetic patients than
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in the general population and can lead to delayed diag-
nosis [6—8]. In addition, even after normal noninvasive
stress testing, event rates are still higher in diabetic
patients than in non-diabetic individuals [9,10], which is
probably related to differences in coronary plaque burden
and composition. Consequently, direct noninvasive imag-
ing of coronary atherosclerotic plaques with MDCT has
become a useful tool in the detection of both calciﬁed
and vulnerable non-calciﬁed coronary lesions, in contrast
to calcium scoring alone, and may allow improved cardio-
vascular risk stratiﬁcation [11—14]. Recent reports have
even demonstrated the ability of contrast-enhanced MDCT
to detect differences in coronary plaque characteristics
between patients with and without symptomatic diabetes
[15]. However, the prevalence and characteristics of coro-
nary plaques detected by MDCT in asymptomatic type 2
diabetic patients have not been evaluated systematically.
The aim of our preliminary cross-sectional study was to
assess prospectively the potential of MDCT to detect coro-
nary artery plaques in asymptomatic type 2 diabetic patients
without known CAD but considered to be at high risk
of CAD because of the presence of carotid atheroscle-
rotic lesions, and to study plaque prevalence, extent and
characteristics.
Methods
Study subjects
The study population consisted of 42 consecutive type 2 dia-
betic patients (28 men; 14 women; mean age 62.1 years;
range 50—77 years) in primary prevention without known
symptoms suggestive of CAD, who were recruited prospec-
tively from an endocrinology department between May 2006
and April 2007. All participants were required to have a
carotid atherosclerotic plaque greater or equal to 1.5mm
thick at inclusion to increase the probability of ﬁnding coro-
nary plaques. This threshold was set arbitrarily to ensure
the selection of diabetic patients with a carotid atheroscle-
rotic plaque that was sufﬁciently thick to be examined
by high-resolution magnetic resonance imaging — a crite-
rion that was part of another study that aimed to identify
the different components of plaques with magnetic reso-
nance imaging. Inclusion criteria were the presence of type
2 diabetes diagnosed according to the American Diabetes
Association criteria (symptoms of diabetes and a casual
plasma glucose level of greater than or equal to 11.1mmol/L
or a fasting plasma glucose level of greater than or equal
to 7.0mmol/L) [16], age at onset greater than or equal to
35 years, current age greater than or equal to 50 years,
no personal history of CAD and normal electrocardiogram
at rest. Exclusion criteria were age at onset of diabetes of
less than 35 years, current age less than 50 years, preg-
nancy, known CAD, Cockroft and Gault creatinine clearance
less than 50mL/min and arrhythmia that did not allow
electrocardiogram-triggering of the MDCT scan. All study-
related data, including patient history, laboratory results
and MDCT ﬁndings were analysed. The study protocol was
approved by the local research ethics committee and all
patients gave written informed consent before inclusion in
the study.
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DCT data acquisition
ll examinations were performed using a MDCT scan
Brilliance 40, Philips Medical Systems, Eindhoven, the
etherlands). First, a native prospective scan without
ontrast enhancement was performed to determine the
otal calcium burden of the coronary tree (sequential
can with 32× 0.6mm collimation, tube current 60mAs at
20 kV), followed by 40-slice contrast-enhanced CT coro-
ary angiography performed with the use of a retrospective
lectrocardiogram-triggered spiral scan of the whole heart
rea with the following parameters: 40× 0.625mm colli-
ation, 420ms gantry rotation, pitch of 0.2, tube voltage
t 120 kV, maximum current of 600—800mAs depending on
atient size, half-scan reconstruction mode and imaging
raniocaudal direction. Tube current was modulated accord-
ng to the electrocardiogram. The average radiation dose
eceived for the study was approximately of 7mSv. Contrast
gent (80mL Iomeron [400mg iodine/mL], Bracco Altana
harma, Milan, Italy) was injected intravenously at a rate of
—6mL/s. Twenty-ﬁve (59.5%) of the 42 enrolled patients
ad a heart rate greater than or equal to 65 beats/min
t the moment of the CT scan, and received metoprolol
—20mg intravenously before the examination. Transaxial
mage reconstruction was performed routinely using a win-
ow centred at 75% of the R-R interval to coincide with left
entricular diastole. For heart rates greater than or equal
o 70 beats/min, an earlier reconstruction phase (40%) was
sed (coinciding with isovolumic relaxation). The position
f the reconstruction window within the cardiac cycle was
ptimized individually to minimize motion artefacts. Image
uality was good enough to allow analysis of MDCT data in
ll patients.
DCT image interpretation
ardiac MDCT image evaluation was performed indepen-
ently on a separate workstation (Brilliance workstation,
hilips Medical Systems, Eindhoven, the Netherlands) by two
eviewers who were unaware of the clinical data. In cases
here disagreement occurred, agreement was reached in a
oint reading. A total Agatston calcium score was recorded
or each patient. MDCT angiograms were analysed visually by
ssessment of the axial slices, the multiplanar reformations
long the axis of the vessel of interest, the cross-sectional
mages perpendicular to the vessel centre line and the
hree thin-slab maximum intensity projections. The coro-
ary artery tree was divided into 15 segments according to
he American Heart Association classiﬁcation [17]. In our
nalysis, segments were separated into proximal (1, 5, 6
nd 11) and distal (2, 3, 4, 7, 8, 9, 10, 12, 13, 14 and 15)
egments. Healthy segments were deﬁned as those without
ny plaque and diseased segments as those containing non-
alciﬁed, mixed or calciﬁed plaques. One coronary plaque
as assigned per coronary segment. Plaques were classiﬁed
s obstructive or non-obstructive using a 50% threshold of
uminal narrowing. The presence of obstructive and non-
bstructive CAD in one vessel (single-vessel disease) or in
wo or three vessels (multivessel disease) was also evalu-
ted. The presence of non-calciﬁed or hypodense plaques
as deﬁned as any discernible protrusive structure in the
oronary artery wall with a CT density less than the contrast-
6 R. Loffroy et al.
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Table 1 Characteristics of our study population of 42
patients.
Characteristic Data
Age (years) 62.1± 7.9
Men 28 (66.7)
Duration of diabetes (years) 14.2± 8.4
Smoking 5 (11.9)
Arterial hypertension 32 (76.2)
Weight (kg) 83.5± 13.4
Waist circumference (cm) 101± 11.2
Body mass index (kg/m2) 29.1± 4.7
Plasma triglycerides (g/L) 1.46± 0.95
Total cholesterol (g/L) 1.80± 0.38
High-density lipoprotein
cholesterol (g/L)
0.54± 0.17
Low-density lipoprotein
cholesterol (g/L)
0.98± 0.28
C-reactive protein (mg/L) 3.42± 3.24
Carotid intima-media thickness
(mm)
0.843± 0.133
Glycosylated haemoglobin (g/L) 8.13± 1.57
Microalbuminuria 13 (30.9)
Creatinine clearancea (mL/min) 98.3± 23.9
Results are given as mean± standard deviation or n (percent-
age).
n
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nhanced coronary lumen but greater than the surrounding
onnective tissue. Calciﬁed atherosclerotic plaques were
eﬁned as plaques with high density exceeding the thresh-
ld of 130Hounsﬁeld units. In other words, any isolated
oronary artery wall calciﬁcation was considered to be a cal-
iﬁed coronary plaque, whatever its protrusion in the lumen.
ixed plaques were deﬁned as plaques with non-calciﬁed
nd calciﬁed components within the same plaque. Plaques
ere also classiﬁed as extensive and non-extensive using a
0% threshold of length spreading.
tatistical analysis
ontinuous variables are expressed as mean± standard devi-
tion and were compared using the two-tailed t test for
ndependent samples. When not distributed normally, con-
inuous variables are expressed as median (interquartile
ange) and were compared using the non-parametric Mann-
hitney test. Categorical variables are expressed as number
percentage) and compared between groups with the 2 or
isher’s exact test. All statistical analyses were performed
sing Triomphe software [18] and Stata software (StataCorp,
005; Stata statistical software: release 9.0. College Sta-
ion, TX, USA). For all analyses, a p-value of less than 0.05
as considered to be the threshold of signiﬁcance.
esults
coronary MDCT investigation was performed in 42 type
diabetic patients and a total of 630 coronary segments
ere included in the analysis. The general characteristics
f the study population are summarized in Table 1. Diabetes
n our series was treated as in the overall diabetic popula-
ion; all patients had oral antidiabetic medication or insulin
herapy. No coronary calciﬁcations were present in 15 of
2 (35.7%) patients, whereas calciﬁed plaques were noted
n 27 of 42 (64.3%) patients (Fig. 1). Subsequent contrast-
nhanced coronary CT angiography revealed the presence of
igure 1. Prevalence of calciﬁed and non-calciﬁed plaques in the
tudy group. CAD: coronary artery disease; CT: computed tomogra-
hy.
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ra According to Cockroft and Gault formula.
on-calciﬁed plaques in four of 15 (26.7%) patients who had
o coronary calciﬁcations. In these patients, non-calciﬁed
laques were the only manifestation of CAD. The over-
ll prevalence of patients with non-calciﬁed plaques as
he only manifestation of CAD was 9.5% (4/42 patients).
n patients with coronary calciﬁcations, additional non-
alciﬁed plaques were detected in six of 27 (22.2%) patients.
In summary, CAD because of the presence of calciﬁed or
on-calciﬁed plaques was detected in a total of 31 (73.8%)
atients. In the remaining 11 (26.2%) patients, CAD was
ompletely absent on MDCT. The proportion of men was sig-
iﬁcantly higher in patients with CAD (sex-ratio 3.4) and
n patients with calciﬁed plaques (sex-ratio 4.2) compared
ith in patients without CAD (sex-ratio 0.57) and without
alciﬁed plaques (sex-ratio 0.77), respectively. Patients with
AD, calciﬁed plaques or non-calciﬁed plaques were charac-
erized by slightly higher total cholesterol and low-density
ipoprotein concentrations. In addition, patients with CAD
r calciﬁed plaques were characterized by a trend of hav-
ng a greater cIMT than patients with non-calciﬁed plaques.
inally, the mean glycosylated haemoglobin level was signiﬁ-
antly higher in patients with CAD than in those without CAD
mean 8.90± 1.29 g/L vs 7.86± 1.57 g/L; p < 0.05). Table 2
ummarizes the clinical and biological characteristics of dia-
etic patients with and without CAD in more detail.
A total Agatston calcium score of zero or 1—10 was
bserved in 15 (35.7%) and no (0%) patients, respectively.
calcium score of 11—100 was observed in nine (21.4%)
atients, while a score of 101—400 or greater than 400
as identiﬁed in seven (16.7%) and 11 (26.2%) patients,
espectively. The presence of obstructive disease was noted
CT of coronary plaques in type 2 diabetes 611
Table 2 Clinical and biological characteristics of diabetic patients with and without coronary artery disease.
Patients with CAD (n = 31) Patients without CAD (n = 11) p
Age (years) 62.6± 7.5 60.7± 8.7 0.55
Men 24 (77.4) 4 (36.4) 0.024
Duration of diabetes (years) 13.9± 8.4 15.1± 9.5 0.81
Smoking 4 (12.9) 1 (9.1) 1.00
Arterial hypertension 23 (74.2) 9 (81.8) 0.71
Waist circumference (cm) 101.6± 11.5 99.4± 11.2 0.71
Body mass index (kg/m2) 28.6± 4.1 30.6± 6.2 0.56
Plasmatic triglycerides (g/L) 1.47± 0.99 1.40± 0.82 1.00
Total cholesterol (g/L) 1.84± 0.38 1.68± 0.19 0.20
High-density lipoprotein cholesterol (g/L) 0.54± 0.17 0.54± 0.15 0.62
Low-density lipoprotein cholesterol (g/L) 1± 0.29 0.91± 0.26 0.30
C-reactive protein (mg/L) 3.32± 3.45 3.48± 2.67 0.50
Carotid intima-media thickness (mm) 0.855± 0.143 0.809± 0.096 0.39
Glycosylated haemoglobin (g/L) 8.90± 1.29 7.86± 1.57 0.03
Results are given as mean± standard deviation or n (percentage).
p < 0.05 was statistically signiﬁcant.
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[CAD: coronary artery disease
in nine of 11 patients with a high calcium score (> 400).
The mean number of diseased segments and the mean
number of segments containing calciﬁed plaques were
signiﬁcantly higher in men than in women: 4.53± 3.8 ver-
sus 1.35± 1.78 (p < 0.05) and 3.46± 3.3 versus 0.78± 1.18
(p < 0.05), respectively. In the 31 (73.8%) patients with CAD,
147 (31.6%) coronary segments with plaques were observed
among a total of 465 coronary segments. Of the segments
containing plaques, 114 (77.5%) showed non-obstructive
CAD and 33 (22.5%) showed obstructive CAD. Single-vessel
disease was observed in 6/12 (50%) patients with obstruc-
tive CAD; the other six (50%) patients with obstructive
CAD had multivessel disease. Most calciﬁed (n = 96; 88.9%)
and non-calciﬁed (n = 10; 90.9%) plaques resulted in lumen
narrowing of less than 50%, whereas most mixed plaques
(n = 20; 71.4%) resulted in lumen narrowing in more than
50%. Of the segments containing non-obstructive plaques,
85 (74.6%) showed non-extensive and 29 (25.4%) showed
extensive CAD, whereas six (18.2%) and 27 (81.8%) seg-
ments with obstructive plaques contained non-extensive and
extensive plaques, respectively. In general, non-calciﬁed
plaques were observed in 11 (7.5%) segments, mixed plaques
in 28 (19%) segments, and calciﬁed plaques in 108 (73.5%)
segments. Most segments with calciﬁed (n = 64; 59.3%) or
mixed (n = 16; 57.2%) plaques were distal segments, whereas
most segments with non-calciﬁed plaques (n = 7; 63.6%) were
proximal segments. Table 3 summarizes the distribution of
coronary plaques according to their characteristics.
Discussion
As CAD is the major cause of the morbidity, mortality and
medical cost of diabetes [19], early diagnosis of CAD to pre-
vent progression and clinical events has intuitive appeal.
Several studies have documented the ability of MDCT to
visualize coronary atherosclerotic plaques in vivo [20—24].
Possible applications in the risk stratiﬁcation of asymp-
h
t
o
(
womatic individuals have been discussed but require close
crutiny of the actual ability of MDCT to detect non-stenotic
oronary plaques. Our study shows, ﬁrstly, that in asymp-
omatic subjects considered at high risk of CAD because
f type 2 diabetes and the concomitant presence of a sig-
iﬁcant carotid atherosclerotic plaque, CAD is completely
bsent on MDCT in a high proportion (26.2%) of patients.
hese patients were characterized by a trend of having
ower total cholesterol and low-density lipoprotein choles-
erol concentrations and a smaller cIMT. This observation
upports the fact that cIMT is a marker of atherosclerosis
urden, as reported previously [25], and that increased cIMT
n diabetes is associated with risk factors for atherosclerosis,
nd even with coronary and cerebral vascular events [26].
n addition, in the 31 (73.8%) patients with CAD, 147 (31.6%)
oronary segments with plaques were observed among a
otal of 465 coronary segments, meaning that atheroma-
ous burden per patient was slightly low and that our study
opulation was at lower risk than was thought. However,
he control of diabetes was statistically worse in patients
ith CAD than in patients without CAD (mean glycosylated
aemoglobin level 8.90± 1.29 vs 7.86± 1.57, respectively;
< 0.05), which may represent a confounding factor in our
tudy.
Sex was associated signiﬁcantly with increased CAD and
AC in our study. Age and smoking were also associated with
ncreased CAD and CAC, but the association did not reach
tatistical signiﬁcance, probably because of the small num-
er of patients. The volume of CAC is an excellent marker
f overall atherosclerotic burden [27,28]. Calcium deposi-
ion occurs only when atherosclerosis is present and more
evere plaques tend to have a greater amount of calcium
29]. Therefore, higher CAC scores are associated with a
igher likelihood of signiﬁcant coronary stenosis, whereas
he absence of CAC is associated with a very low likelihood
f obstructive CAD. In our population-based study, 16 of 42
38.1%) asymptomatic subjects had some evidence of CAC,
hereas 11 of 42 (26.2%) had a CAC score greater than 400.
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his proportion is higher than in non-diabetic patients, as
eported by Schurgin et al. [30], who screened a cohort of
39 asymptomatic diabetic patients and matched control
ubjects. They concluded that extensive CAC (calcium score
400) was more prevalent (25.9%) in diabetic patients than
on-diabetic control subjects both without (7.2%) and with
14%) traditional risk factors. These ﬁndings are of interest,
s a calcium score higher than 400 is associated with a high
isk of myocardial perfusion impairment [31] and a high risk
f any cardiovascular event in the short term [32]. In our
tudy, the presence of obstructive disease was noted in nine
f 11 patients with a high calcium score (> 400). In fact, 27
f 33 (81.8%) obstructive plaques were extensive.
Several studies have shown that the coronary artery
alcium score is valuable in identifying patients with a
igh likelihood of inducible myocardial ischaemia [31,33].
hese studies have observed consistently that the likeli-
ood of ischaemia in patients with a calcium score less
han 100 is negligible, whereas those with a score greater
han or equal to 400 have a relatively high likelihood of
nducible ischaemia. Anand et al. [34] studied asymptomatic
atients with diabetes and conﬁrmed the higher incidence of
nducible ischaemia in patients with higher calcium scores.
early one third of those patients had a calcium score higher
han 400, 28% of whom had large ischaemic defects. On
he other hand, our prospective study indicated that mixed
nd non-calciﬁed coronary plaques and their characteristics
an be detected accurately with 40-slice CT angiography.
n addition, our study showed that non-calciﬁed coronary
laques, alone or in combination with calciﬁcations, can also
e detected in a high proportion of asymptomatic type 2 dia-
etic patients. Furthermore, our study demonstrated that
on-calciﬁed coronary plaques were the only manifestation
f CAD in 9.5% of the study population (or in 26.7% of patients
ith a negative score for coronary calciﬁcations). These
ndings demonstrate that calcium scoring with a prospec-
ive scan without contrast enhancement is not sufﬁcient
o determine the presence of coronary plaques. Patients
ith a high cardiovascular risk, as in our study, should have
ontrast-enhanced CT coronary angiography in cases of neg-
tive scan for calcium. Indeed, in a recent population study
f 70 asymptomatic patients with type 2 diabetes, Scholte
t al. [35] showed a relatively high proportion (41%) of non-
alciﬁed plaques detected by MDCT. Importantly, a calcium
core less than 10 did not exclude CAD in these patients. The
uthor concluded that MDCT might be a useful technique
or identifying CAD in asymptomatic patients with type 2
iabetes with incremental value over calcium scoring.
The identiﬁcation of patients at increased risk of an
schaemic and potentially fatal cardiac event is a difﬁcult
ask in cardiovascular medicine. Despite extensive stud-
es and the development of several risk-prediction models,
raditional cardiovascular risk factors fail to predict the
evelopment of CAD in a large group of patients [36]. MDCT
ngiography has been introduced as a noninvasive tech-
ique for the reliable detection of coronary stenosis in
ddition to quantiﬁcation of calciﬁed plaque burden [37].
ith the improved spatial resolution, CT angiography also
llows for the detection of mixed and non-calciﬁed coro-
ary plaques. Sensitivity and speciﬁcity of 78% and 87—92%,
espectively, have been reported by Leber et al. [13] and
chenbach et al. [11] for 16-slice CT for the detection of
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RCT of coronary plaques in type 2 diabetes
non-calciﬁed plaques, alone or in combination with calciﬁed
plaques, compared with intravascular ultrasound. Of inter-
est, patients with non-calciﬁed plaques were characterized
by a trend of having higher total cholesterol, low-density
lipoprotein cholesterol and CRP levels. Although no associa-
tion between CRP and the calciﬁed plaque burden was found
in the Study of Inherited Risk of Coronary Atherosclerosis
[38], Hausleiter et al. [39] demonstrated that CRP val-
ues were signiﬁcantly higher in patients with non-calciﬁed
plaques and that these elevated values correlated with
earlier non-calciﬁed stages of atherosclerotic plaque devel-
opment, supporting the association of the inﬂammatory
burden with increased cardiovascular risk [40].
Noninvasive atherosclerosis imaging techniques might
further enhance the detection and management of patients
at risk of coronary heart disease, but they are not per-
fect. It is recognized that a ‘detection gap’ exists, deﬁned
as the difference between coronary heart disease cases
or events currently detected and the total burden of dis-
ease or events among the population [41]. This leaves
room for the introduction of the noninvasive atheroscle-
rosis CT imaging technique. Romeo et al. [42] used MDCT
in 168 asymptomatic high-risk subjects (age 60± 7 years)
and found that the prevalence of signiﬁcant CAD (> 50%
diameter stenosis) was 27%. Most of these subjects were dia-
betic (60%), 36% of whom had evidence of signiﬁcant CAD.
These subjects might beneﬁt from coronary revasculariza-
tion, although studies demonstrating that revascularization
might improve prognosis in asymptomatic subjects are lack-
ing. Well-designed studies need to be conducted to provide
substantial evidence that CT coronary imaging has an inde-
pendent predictive value in addition to common risk factors.
Of interest, a very high proportion of mixed plaques
(71.4%) were obstructive in our study compared with cal-
ciﬁed (11.1%) or non-calciﬁed (9.1%) plaques. Accordingly,
calcium scores may underestimate total coronary plaque
burden to a higher extent in patients with diabetes. MDCT
coronary angiography may therefore have substantial incre-
mental value over coronary calcium scoring, although this
concept needs further study. In our study, MDCT coronary
angiography allowed the identiﬁcation of two phenotypi-
cally different groups of diabetic patients with or without
non-calciﬁed plaques despite an identical cardiovascular
risk (clinical and biological characteristics not statistically
different). Nevertheless, Pundziute et al. [15] reported a
signiﬁcantly lower proportion of mixed coronary plaques
in patients with diabetes (23%) than in patients without
diabetes (38%), suggesting a more rapid development of
atherosclerosis in the presence of diabetes, with faster
progression from non-calciﬁed lesions to completely cal-
ciﬁed lesions. The proportion of mixed coronary plaques
in patients with diabetes was quite similar in our study
(19%). However, the most frequently obstructive charac-
ter of mixed plaques was not obvious in this study. In
addition, most segments with calciﬁed (59.3%) or mixed
(57.2%) plaques were distal segments, whereas most seg-
ments with non-calciﬁed plaques (63.6%) were proximal
segments. These ﬁndings could be attributed to better
visualization of non-calciﬁed plaques in proximal coronary
vessels than in smaller distal segments on CT angiography.
Our study had some limitations. Firstly, this population-
based study was biased, so the prevalence of coronary613
laques can only be valid in this particular population
nd probably cannot be extended to the French stan-
ard diabetic population. Notably, all patients had at least
ne carotid atherosclerotic plaque at inclusion, considering
rbitrarily and intuitively that it was an additional cardio-
ascular risk factor. Secondly, examinations were performed
t a single time point and were not repeated over time. Also,
DCT angiograms were evaluated visually, as no reliable
uantitative algorithms are currently available. Therefore,
ong-term follow-up data, not yet available in our study, are
eeded to determine whether the MDCT observations can
rovide prognostic information and be of potential use in
he identiﬁcation of diabetic patients at different levels of
ardiovascular risk. Because of the relatively small number
f patients, we could not draw deﬁnitive conclusions on the
revalence of coronary plaques by CT in our diabetic pop-
lation and we could not evaluate signiﬁcantly the effect
f risk factors on coronary plaque characteristics. Further
tudies with larger populations should be conducted to clar-
fy this important issue, as well as to conﬁrm the predictive
alue of mild calciﬁcations and non-calciﬁed plaques for
ard coronary events, particularly in type 2 diabetic patients
ithout symptoms. On the other hand, the visualization of
on-calciﬁed plaques by MDCT is limited by plaque and ves-
el size; smaller plaques located predominantly in smaller
oronary arteries may therefore be difﬁcult to identify accu-
ately with the current generation of CT scanners. Finally,
he possible beneﬁts of coronary plaque detection by MDCT
eed to be weighed against the potential hazards associ-
ted with the radiation dose delivered to the chest and the
ecessity for administration of intravenous contrast media.
onclusions
ur study provides the ﬁrst assessment of the accuracy of
DCT in detecting and quantifying coronary atherosclerotic
laques in a subgroup of particular asymptomatic type 2
iabetic patients at high risk of coronary disease. Notably,
T seems to detect a high proportion of coronary plaques
ompared with conventional angiography in these speciﬁc
atients. However, the precise role of MDCT in the diagnostic
ork-up of patients with suspected CAD in relation to exist-
ng noninvasive functional tests is not yet established and, to
ate, the technique is not indicated clinically for coronary
laque detection in asymptomatic diabetic patients.
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